Janssen Biotech, one of Johnson & Johnson's pharma companies, has announced the FDA approval of its ulcerative colitis drug, Simponi for use in the US.
The FDA has approved Simponi (golimumab)... Read more
Sanofi has announced that its rare disease treatment to treat myelofibrosis showed positive results in a late-stage phase 3 clinical trial.
The French drugmaker's pivotal study JAKARTA was evaluating the JAK2... Read more
Bayer's new prostate cancer drug has been approved in the US three months ahead of schedule through the FDA's priority review system.
Xofigo (radium Ra 223 dichloride) has been approved to... Read more
Merck Serono, a division of German's Merck KGaA, has announced a new five-year clinical development agreement with Quintiles. This strategic collaboration is the first-of-its-kind between a biopharma company and a... Read more